高血压合并疾病治疗阈值与降压目标值的进展
Progress of Therapeutic Thresholds andAntihypertensive Targets Value ofHypertension Complicated Disease
摘要: 高血压是我国心血管疾病中发病率最高的疾病，也是大血管靶器官损害或其他心血管病的重要危险因素。同时高血压已成为影响全球死亡率的第二大危险因素。其主要原因在于发病隐匿，其危害的知晓率低，用药依从性差和降压目标值僵硬性应用等多方面原因。现将高血压目前测量标准及其常见伴发的疾病中高血压的启动治疗阈值和降压目标要点综述如下。
Abstract: Hypertension is the disease with the highest incidence of cardiovascular diseases in China, and it is also an important risk factor for macrovascular target organ damage or other cardiovascular diseases. At the same time, hypertension has become the second largest risk factor for global mortality. The main reason is that the disease is hidden, the awareness rate of its harm is low, the compliance of medication is poor, the target value of blood pressure is rigid, and so on. In this paper, the current measurement standards of hypertension and the starting treatment threshold and antihypertensive target of hypertension in common concomitant diseases are summarized as follows.
文章引用：周钰璞, 王营忠, 周文丽. 高血压合并疾病治疗阈值与降压目标值的进展[J]. 临床医学进展, 2021, 11(9): 4345-4350. https://doi.org/10.12677/ACM.2021.119636

参考文献

[1] 中国老年高血压管理指南2019 [J]. 中华老年病研究电子杂志, 2019, 6(2): 1-27.
[2] 甘华葵, 丁燕, 孙毅, 等. 青年人不同类型肥胖症及相关疾病比较[J]. 西部医学, 2011, 23(7): 1260-1261, 1264.
[3] Bryan, W., Giuseppe, M., Wilko, S., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Giornale Italiano Di Cardiologia (Rome), 19, 3S-73S.
[4] Rabi, D.M., Ruth, S., et al. (2020) Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. The Canadian Journal of Cardiology, 36, 596-624.
[5] 中国高血压联盟《动态血压监测指南》委员会. 2020中国动态血压监测指南[J]. 中国循环志, 2021, 36(4): 313-328.
[6] Kario, K., et al. (2019) Expert Panel Consensus Recommendations for Ambulatory Blood Pressure Monitoring in Asia: The Hope Asia Network. The Journal of Clinical Hypertension (Greenwich), 21, 1250-1283. [Google Scholar] [CrossRef] [PubMed]
[7] Guan, T.J., et al. (2017) Rapid Transitions in the Epidemiology of Stroke and Its Risk Factors in China from 2002 to 2013. Neurology, 89, 53-61. [Google Scholar] [CrossRef] 
[8] He, M.L., et al. (2018) Blood Pressures Immediately Following Ischemic Strokes Are Associated with Cerebral Perfusion and Neurologic Function. Journal of Clinical Hypertension (Greenwich, Conn.), 20, 1008-1015. [Google Scholar] [CrossRef] [PubMed]
[9] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版) [J]. 中国心血管杂志, 2019, 24(1): 24-56.
[10] 彭斌, 吴波. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.
[11] Anderson, C.S., et al. (2013) Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. New England Journal of Medicine, 368, 2355-2365.
[12] Qureshi, A.I., et al. (2016) Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. The New England Journal of Medicine, 375, 1033-1043. [Google Scholar] [CrossRef] 
[13] 王拥军, 王春雪, 缪中荣. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014 [J]. 中华神经科杂志, 2015, 48(4): 258-273.
[14] Umemura, S., Arima, H., Arima, S., et al. (2019) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertension Research, 42, 1235-1481. [Google Scholar] [CrossRef] [PubMed]
[15] Cheng, Q. and Zhao, Y.J. (2015) The Reasons for the Failure of the Primary Arteriovenous Fistula Surgery in Patients with End-Stage Renal Disease. The Journal of Vascular Access, 16, S74-S77. [Google Scholar] [CrossRef] [PubMed]
[16] 金其庄, 王玉柱, 叶朝阳, 等. 中国血液透析用血管通路专家共识(第2版) [J]. 中国血液净化, 2019, 18(6): 365-381.
[17] 张宇涵, 马岩, 彭宇, 等. 自体动静脉内瘘血栓危险因素的Meta分析[J]. 中国血液净化, 2021, 20(2): 126-129.
[18] Thomsen, M.B., Deurell, S.I., Elfström, J. and Alm, A. (1983) What Causes the Failures in Surgically Constructed Arteriovenous Fistulas? Acta Chirurgica Scandinavica, 149, 371-376.
[19] 张毅, 陈欣欣, 许扬滨, 等. 前臂自体动静脉内瘘407例早期失用相关因素分析[J]. 中山大学学报(医学科学版), 2009, 30(S2): 96-98, 182.
[20] (2019) ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstetrics and Gynecology, 133, 215-219. [Google Scholar] [CrossRef] 
[21] Amro, F.H., Moussa, H.N., Ashimi, O.A. and Sibai, B.M. (2016) Treatment Options for Hypertension in Pregnancy and Puerperium. Expert Opinion on Drug Safety, 15, 1635-1642. [Google Scholar] [CrossRef] [PubMed]
[22] Webster, K., Fishburn, S., Maresh, M., et al. (2019) Diagnosis and Management of Hypertension in Pregnancy: Summary of Updated Nice Guidance. BMJ, 366, L5119. [Google Scholar] [CrossRef] [PubMed]
[23] 北京高血压防治协会(BHA), 北京糖尿病防治协会, 北京慢性病防治与健康教育研究会, 中国高血压联盟, 中国老年保健协会, 养老与健康专业委员会, 国家老年疾病临床医学研究中心, 中国老年心血管病防治联盟. 基层心血管病综合管理实践指南2020 [J]. 中国医学前沿杂志(电子版), 2020, 12(8): 1-73.
[24] 张新军. 降压治疗策略应基于血压水平还是总体心血管病风险[J]. 中华高血压杂志, 2020, 28(1): 6-10.
[25] 刘靖. 高血压治疗: 基于血压水平和心血管病风险的降压策略过时了吗?——2020 “降压治疗试验协作组”荟萃分析的争议与思考[J]. 中华高血压杂志, 2021, 29(1): 2-3.

为你推荐